BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2573092)

  • 1. Exploitation of biotechnology in a smaller company.
    Fairtlough GH
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):589-97. PubMed ID: 2573092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploitation of biotechnology in a large company.
    Dart EC
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):599-611. PubMed ID: 2573093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from an exploratory study to identify the factors that contribute to success for UK medical device small- and medium-sized enterprises.
    Hourd PC; Williams DJ
    Proc Inst Mech Eng H; 2008 Jul; 222(5):717-35. PubMed ID: 18756690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotechnology: Celltech to change hands?
    Newark P
    Nature; 1989 Nov; 342(6248):334. PubMed ID: 2586596
    [No Abstract]   [Full Text] [Related]  

  • 6. From applied microbiology to biotechnology: science, medicine and industrial renewal.
    Bud R
    Notes Rec R Soc Lond; 2010 Sep; 64 Suppl 1():S17-29. PubMed ID: 20973345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating knowledge structures in the pharmaceutical industry: the increasing significance of virtual organisation.
    Salazar A; Howells J
    World Hosp Health Serv; 2000; 36(2):6-10, 44-5. PubMed ID: 11214458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invention and business performance in the tissue-engineering industry.
    Pangarkar N; Hutmacher DW
    Tissue Eng; 2003 Dec; 9(6):1313-22. PubMed ID: 14670118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management and coordination of biotechnology in the U.K. 1980-88.
    Sharp M
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):509-20; discussion 520-3. PubMed ID: 2573088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Task force recommendations to transform UK industry.
    Wilkinson J
    Med Device Technol; 2004 Dec; 15(10):36-7. PubMed ID: 16225284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond and between academia and business: How Austrian biotechnology researchers describe high-tech startup companies as spaces of knowledge production.
    Fochler M
    Soc Stud Sci; 2016 Apr; 46(2):259-81. PubMed ID: 27263239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small company mergers--good for whom?
    Maybeck V; Bains W
    Nat Biotechnol; 2006 Nov; 24(11):1343-8. PubMed ID: 17093475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case studies of innovative medical device companies from India: barriers and enablers to development.
    Jarosławski S; Saberwal G
    BMC Health Serv Res; 2013 May; 13():199. PubMed ID: 23721110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 16. Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016.
    McNamee LM; Cleary EG; Zhang S; Salim U; Ledley FD
    Clin Ther; 2021 Jan; 43(1):156-171.e15. PubMed ID: 33380363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 19. The benefits of design partnership.
    Hogan J
    Med Device Technol; 2005 May; 16(4):34-5. PubMed ID: 15941198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to innovation in medical device manufacture.
    McKay I
    Med Device Technol; 2004 Jun; 15(5):24-6. PubMed ID: 15285484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.